nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—DHCR7—Vitamin D Metabolism—PTH—nephrolithiasis	0.0348	0.42	CbGpPWpGaD
Epirubicin—CHD1—nephron tubule—nephrolithiasis	0.0299	0.122	CbGeAlD
Epirubicin—CHD1—cortex of kidney—nephrolithiasis	0.0256	0.104	CbGeAlD
Epirubicin—AURKA—renal system—nephrolithiasis	0.0219	0.0891	CbGeAlD
Epirubicin—AURKA—kidney—nephrolithiasis	0.0212	0.0861	CbGeAlD
Epirubicin—DHCR7—nephron tubule—nephrolithiasis	0.0202	0.082	CbGeAlD
Epirubicin—DHCR7—cortex of kidney—nephrolithiasis	0.0173	0.0702	CbGeAlD
Epirubicin—YWHAG—renal system—nephrolithiasis	0.0168	0.0684	CbGeAlD
Epirubicin—YWHAG—kidney—nephrolithiasis	0.0163	0.0661	CbGeAlD
Epirubicin—YWHAG—cortex of kidney—nephrolithiasis	0.0158	0.0644	CbGeAlD
Epirubicin—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0153	0.0227	CcSEcCtD
Epirubicin—UGT2B7—renal system—nephrolithiasis	0.0152	0.0618	CbGeAlD
Epirubicin—UGT2B7—kidney—nephrolithiasis	0.0147	0.0597	CbGeAlD
Epirubicin—Serum creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.013	0.0194	CcSEcCtD
Epirubicin—PLA2G4A—renal system—nephrolithiasis	0.0125	0.051	CbGeAlD
Epirubicin—PLA2G4A—cortex of kidney—nephrolithiasis	0.0118	0.048	CbGeAlD
Epirubicin—Hyperlipidaemia—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0166	CcSEcCtD
Epirubicin—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0108	0.0161	CcSEcCtD
Epirubicin—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0152	CcSEcCtD
Epirubicin—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0099	0.0148	CcSEcCtD
Epirubicin—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0099	0.0148	CcSEcCtD
Epirubicin—Jaundice cholestatic—Hydrochlorothiazide—nephrolithiasis	0.00913	0.0136	CcSEcCtD
Epirubicin—Hyperuricaemia—Hydrochlorothiazide—nephrolithiasis	0.00865	0.0129	CcSEcCtD
Epirubicin—Nocturia—Hydrochlorothiazide—nephrolithiasis	0.00865	0.0129	CcSEcCtD
Epirubicin—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.00838	0.0125	CcSEcCtD
Epirubicin—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.00817	0.0122	CcSEcCtD
Epirubicin—Blood uric acid increased—Hydrochlorothiazide—nephrolithiasis	0.00817	0.0122	CcSEcCtD
Epirubicin—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.00812	0.0121	CcSEcCtD
Epirubicin—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00802	0.012	CcSEcCtD
Epirubicin—Hyperkalaemia—Hydrochlorothiazide—nephrolithiasis	0.00788	0.0117	CcSEcCtD
Epirubicin—Blood urea increased—Hydrochlorothiazide—nephrolithiasis	0.00757	0.0113	CcSEcCtD
Epirubicin—Aplastic anaemia—Hydrochlorothiazide—nephrolithiasis	0.00753	0.0112	CcSEcCtD
Epirubicin—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00733	0.0109	CcSEcCtD
Epirubicin—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.00725	0.0108	CcSEcCtD
Epirubicin—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.00714	0.0106	CcSEcCtD
Epirubicin—ABCC1—cortex of kidney—nephrolithiasis	0.00675	0.0275	CbGeAlD
Epirubicin—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.0067	0.00997	CcSEcCtD
Epirubicin—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.00663	0.00988	CcSEcCtD
Epirubicin—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00651	0.0097	CcSEcCtD
Epirubicin—Hot flush—Hydrochlorothiazide—nephrolithiasis	0.00623	0.00927	CcSEcCtD
Epirubicin—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0062	0.00923	CcSEcCtD
Epirubicin—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00617	0.00919	CcSEcCtD
Epirubicin—Menopausal symptoms—Hydrochlorothiazide—nephrolithiasis	0.00617	0.00919	CcSEcCtD
Epirubicin—Renal impairment—Hydrochlorothiazide—nephrolithiasis	0.00612	0.00912	CcSEcCtD
Epirubicin—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00604	0.009	CcSEcCtD
Epirubicin—Hyponatraemia—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00871	CcSEcCtD
Epirubicin—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00868	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Hydrochlorothiazide—nephrolithiasis	0.00582	0.00868	CcSEcCtD
Epirubicin—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00854	CcSEcCtD
Epirubicin—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00573	0.00854	CcSEcCtD
Epirubicin—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00838	CcSEcCtD
Epirubicin—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00552	0.00822	CcSEcCtD
Epirubicin—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00548	0.00816	CcSEcCtD
Epirubicin—Blood creatinine increased—Hydrochlorothiazide—nephrolithiasis	0.00546	0.00813	CcSEcCtD
Epirubicin—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00538	0.00801	CcSEcCtD
Epirubicin—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00534	0.00795	CcSEcCtD
Epirubicin—Orthostatic hypotension—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00792	CcSEcCtD
Epirubicin—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00532	0.00792	CcSEcCtD
Epirubicin—Hypokalaemia—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0079	CcSEcCtD
Epirubicin—Breast disorder—Hydrochlorothiazide—nephrolithiasis	0.00526	0.00784	CcSEcCtD
Epirubicin—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00781	CcSEcCtD
Epirubicin—Aspartate aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00781	CcSEcCtD
Epirubicin—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00515	0.00768	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00765	CcSEcCtD
Epirubicin—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00514	0.00765	CcSEcCtD
Epirubicin—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00755	CcSEcCtD
Epirubicin—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00503	0.0075	CcSEcCtD
Epirubicin—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00503	0.0075	CcSEcCtD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00501	0.0605	CbGpPWpGaD
Epirubicin—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.00494	0.00735	CcSEcCtD
Epirubicin—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.0049	0.0073	CcSEcCtD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—RGS14—nephrolithiasis	0.00485	0.0586	CbGpPWpGaD
Epirubicin—Dysuria—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00701	CcSEcCtD
Epirubicin—Neutropenia—Hydrochlorothiazide—nephrolithiasis	0.00471	0.00701	CcSEcCtD
Epirubicin—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.00468	0.00697	CcSEcCtD
Epirubicin—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00465	0.00693	CcSEcCtD
Epirubicin—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.00459	0.00684	CcSEcCtD
Epirubicin—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00458	0.00682	CcSEcCtD
Epirubicin—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.00454	0.00676	CcSEcCtD
Epirubicin—Pneumonia—Hydrochlorothiazide—nephrolithiasis	0.00451	0.00672	CcSEcCtD
Epirubicin—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.00445	0.00663	CcSEcCtD
Epirubicin—Renal failure—Hydrochlorothiazide—nephrolithiasis	0.00441	0.00657	CcSEcCtD
Epirubicin—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0044	0.00655	CcSEcCtD
Epirubicin—Jaundice—Hydrochlorothiazide—nephrolithiasis	0.00437	0.00652	CcSEcCtD
Epirubicin—Urinary tract infection—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0065	CcSEcCtD
Epirubicin—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00436	0.0065	CcSEcCtD
Epirubicin—Sweating—Hydrochlorothiazide—nephrolithiasis	0.0043	0.00641	CcSEcCtD
Epirubicin—Haematuria—Hydrochlorothiazide—nephrolithiasis	0.00428	0.00637	CcSEcCtD
Epirubicin—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.00423	0.00631	CcSEcCtD
Epirubicin—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00421	0.00627	CcSEcCtD
Epirubicin—Agranulocytosis—Hydrochlorothiazide—nephrolithiasis	0.00419	0.00624	CcSEcCtD
Epirubicin—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0041	0.00611	CcSEcCtD
Epirubicin—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00602	CcSEcCtD
Epirubicin—Hepatitis—Hydrochlorothiazide—nephrolithiasis	0.00403	0.006	CcSEcCtD
Epirubicin—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00597	CcSEcCtD
Epirubicin—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.004	0.00596	CcSEcCtD
Epirubicin—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00397	0.00591	CcSEcCtD
Epirubicin—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00388	0.00578	CcSEcCtD
Epirubicin—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00567	CcSEcCtD
Epirubicin—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.00376	0.0056	CcSEcCtD
Epirubicin—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00374	0.00557	CcSEcCtD
Epirubicin—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00536	CcSEcCtD
Epirubicin—UGT2B7—Phase II conjugation—SLC26A1—nephrolithiasis	0.00357	0.0431	CbGpPWpGaD
Epirubicin—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00356	0.0053	CcSEcCtD
Epirubicin—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00351	0.00522	CcSEcCtD
Epirubicin—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00346	0.00515	CcSEcCtD
Epirubicin—Tension—Hydrochlorothiazide—nephrolithiasis	0.00344	0.00513	CcSEcCtD
Epirubicin—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00343	0.00512	CcSEcCtD
Epirubicin—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00507	CcSEcCtD
Epirubicin—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00339	0.00505	CcSEcCtD
Epirubicin—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00337	0.00502	CcSEcCtD
Epirubicin—Vision blurred—Hydrochlorothiazide—nephrolithiasis	0.00331	0.00492	CcSEcCtD
Epirubicin—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00485	CcSEcCtD
Epirubicin—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00324	0.00483	CcSEcCtD
Epirubicin—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00322	0.0048	CcSEcCtD
Epirubicin—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00316	0.00471	CcSEcCtD
Epirubicin—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00469	CcSEcCtD
Epirubicin—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00469	CcSEcCtD
Epirubicin—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00314	0.00468	CcSEcCtD
Epirubicin—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.0031	0.00462	CcSEcCtD
Epirubicin—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00308	0.00459	CcSEcCtD
Epirubicin—Cough—Hydrochlorothiazide—nephrolithiasis	0.00306	0.00456	CcSEcCtD
Epirubicin—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00445	CcSEcCtD
Epirubicin—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00445	CcSEcCtD
Epirubicin—Chest pain—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00445	CcSEcCtD
Epirubicin—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.00298	0.00443	CcSEcCtD
Epirubicin—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00295	0.00439	CcSEcCtD
Epirubicin—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00292	0.00435	CcSEcCtD
Epirubicin—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00289	0.0043	CcSEcCtD
Epirubicin—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00426	CcSEcCtD
Epirubicin—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00286	0.00426	CcSEcCtD
Epirubicin—Shock—Hydrochlorothiazide—nephrolithiasis	0.00282	0.0042	CcSEcCtD
Epirubicin—Thrombocytopenia—Hydrochlorothiazide—nephrolithiasis	0.0028	0.00418	CcSEcCtD
Epirubicin—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00279	0.00416	CcSEcCtD
Epirubicin—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00277	0.00412	CcSEcCtD
Epirubicin—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00273	0.00406	CcSEcCtD
Epirubicin—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00267	0.00398	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00261	0.00389	CcSEcCtD
Epirubicin—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00386	CcSEcCtD
Epirubicin—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00257	0.00383	CcSEcCtD
Epirubicin—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00255	0.0038	CcSEcCtD
Epirubicin—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00254	0.00379	CcSEcCtD
Epirubicin—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00252	0.00375	CcSEcCtD
Epirubicin—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00249	0.00371	CcSEcCtD
Epirubicin—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00247	0.00368	CcSEcCtD
Epirubicin—Pain—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00365	CcSEcCtD
Epirubicin—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00245	0.00365	CcSEcCtD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.00245	0.0295	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—SLC2A9—nephrolithiasis	0.00238	0.0288	CbGpPWpGaD
Epirubicin—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00236	0.00351	CcSEcCtD
Epirubicin—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00234	0.00349	CcSEcCtD
Epirubicin—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00227	0.00339	CcSEcCtD
Epirubicin—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00226	0.00337	CcSEcCtD
Epirubicin—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00226	0.00337	CcSEcCtD
Epirubicin—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00211	0.00314	CcSEcCtD
Epirubicin—UGT2B7—Biological oxidations—SLC26A1—nephrolithiasis	0.00209	0.0252	CbGpPWpGaD
Epirubicin—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00205	0.00306	CcSEcCtD
Epirubicin—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00203	0.00302	CcSEcCtD
Epirubicin—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00196	0.00292	CcSEcCtD
Epirubicin—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00189	0.00282	CcSEcCtD
Epirubicin—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00182	0.00271	CcSEcCtD
Epirubicin—Rash—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00269	CcSEcCtD
Epirubicin—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0018	0.00269	CcSEcCtD
Epirubicin—Headache—Hydrochlorothiazide—nephrolithiasis	0.00179	0.00267	CcSEcCtD
Epirubicin—Nausea—Hydrochlorothiazide—nephrolithiasis	0.0017	0.00253	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.0015	0.0181	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GRHPR—nephrolithiasis	0.00137	0.0165	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AGXT—nephrolithiasis	0.00122	0.0147	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00104	0.0126	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00104	0.0126	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—APRT—nephrolithiasis	0.00104	0.0125	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—SLC26A1—nephrolithiasis	0.00104	0.0125	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000929	0.0112	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000849	0.0103	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000849	0.0103	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—DGKH—nephrolithiasis	0.000771	0.00931	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SLC7A9—nephrolithiasis	0.000771	0.00931	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—AQP1—nephrolithiasis	0.000738	0.00891	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CHRM3—nephrolithiasis	0.000668	0.00806	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—RGS14—nephrolithiasis	0.000655	0.00791	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000644	0.00777	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000644	0.00777	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000598	0.00722	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000598	0.00722	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000533	0.00644	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000533	0.00644	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GRHPR—nephrolithiasis	0.000472	0.0057	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GRHPR—nephrolithiasis	0.000463	0.00559	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADCY10—nephrolithiasis	0.000455	0.00549	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—DGKH—nephrolithiasis	0.000442	0.00534	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000426	0.00515	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AGXT—nephrolithiasis	0.000421	0.00508	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AGXT—nephrolithiasis	0.000412	0.00498	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RGS14—nephrolithiasis	0.000387	0.00467	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GRHPR—nephrolithiasis	0.00037	0.00446	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—SLC26A1—nephrolithiasis	0.000358	0.00432	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—APRT—nephrolithiasis	0.000358	0.00432	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—APRT—nephrolithiasis	0.000351	0.00423	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—SLC26A1—nephrolithiasis	0.000351	0.00423	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SLC26A1—nephrolithiasis	0.000335	0.00404	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AGXT—nephrolithiasis	0.00033	0.00398	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CHRM3—nephrolithiasis	0.00032	0.00386	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ATP6V0A4—nephrolithiasis	0.000298	0.0036	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTH—nephrolithiasis	0.000293	0.00353	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—APRT—nephrolithiasis	0.00028	0.00338	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—SLC26A1—nephrolithiasis	0.00028	0.00338	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000261	0.00316	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DGKH—nephrolithiasis	0.000261	0.00316	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—AQP1—nephrolithiasis	0.000255	0.00308	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—AQP1—nephrolithiasis	0.00025	0.00302	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CHRM3—nephrolithiasis	0.00023	0.00278	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CHRM3—nephrolithiasis	0.000226	0.00273	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—AQP1—nephrolithiasis	0.0002	0.00241	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CHRM3—nephrolithiasis	0.000189	0.00228	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CHRM3—nephrolithiasis	0.000181	0.00218	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTH—nephrolithiasis	0.000173	0.00209	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—nephrolithiasis	8.68e-05	0.00105	CbGpPWpGaD
